Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zika virus envelope (E) glycoprotein is the primary protein on the viral surface, organized into 90 homodimers that form a herringbone pattern (Sankhala et al., 2023). The quaternary epitope at the dimer-dimer interface is a complex antigenic site formed by the juxtaposition of two adjacent E protein dimers on the mature virion (Sapparapu et al., 2016). This epitope is a critical target for potently neutralizing human monoclonal antibodies, such as ZIKV-117, which bind across the interface to lock the dimers in place (Zhang et al., 2016). By stabilizing the dimeric structure, these antibodies prevent the large-scale conformational changes—specifically the transition from dimers to fusogenic trimers—required for membrane fusion and viral entry into host cells (Long et al., 2020). Targeting this specific quaternary structure is a key strategy in developing ZIKV-specific therapeutics and vaccines that aim to provide high potency while minimizing the risk of antibody-dependent enhancement (ADE) associated with cross-reactive antibodies to other flaviviruses like Dengue (Sankhala et al., 2023).
Neutralization of viral infection by binding across adjacent envelope protein dimers to stabilize the mature virion structure and inhibit the dimer-to-trimer transition required for membrane fusion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zika virus envelope glycoprotein quaternary dimer-dimer interface epitope (ZIKV E dimer-dimer epitope).